NASDAQ: MIRMMirum Pharmaceuticals Inc Stock Ownership - Who owns Mirum Pharmaceuticals?
Insider buying vs selling
Have Mirum Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael G. Grey | Director | 2025-12-01 | 50,000 | $2.94 | $146.80kBuy |
| Michael G. Grey | Director | 2025-12-01 | 50,000 | $74.00 | $3.70MSell |
| Michael G. Grey | Director | 2025-11-21 | 50,000 | $2.94 | $146.80kBuy |
| Michael G. Grey | Director | 2025-11-21 | 50,000 | $70.00 | $3.50MSell |
| Christopher Peetz | CHIEF EXECUTIVE OFFICER | 2025-11-18 | 19,133 | $19.24 | $368.12kBuy |
| Eric Bjerkholt | CHIEF FINANCIAL OFFICER | 2025-09-12 | 9,578 | $76.01 | $728.02kSell |
| Laura Brege | Director | 2025-09-11 | 1,491 | $75.07 | $111.93kSell |
| Laura Brege | Director | 2025-09-11 | 15,509 | $74.34 | $1.15MSell |
| Laura Brege | Director | 2025-09-11 | 17,000 | $15.00 | $255.00kBuy |
| Saira Ramasastry | Director | 2025-09-08 | 17,000 | $23.51 | $399.67kBuy |
MIRM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MIRM insiders and whales buy or sell their stock.
MIRM Shareholders
What type of owners hold Mirum Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Frazier Life Sciences Management LP | 13.22% | 6,795,121 | $439.44M | Institution |
| Janus Henderson Group PLC | 9.72% | 4,997,586 | $323.19M | Institution |
| Peter J. Barris | 8.15% | 4,186,243 | $270.72M | Insider |
| Peter W. Sonsini | 8.15% | 4,186,243 | $270.72M | Insider |
| David M. Mott | 8.15% | 4,186,243 | $270.72M | Insider |
| Joshua Makower | 8.15% | 4,186,243 | $270.72M | Insider |
| Patrick J. Heron | 7.28% | 3,741,287 | $241.95M | Insider |
| Blackrock Inc | 7.01% | 3,602,434 | $232.97M | Institution |
| Frazier Life Sciences IX LP | 6.94% | 3,566,912 | $230.67M | Insider |
| James E. Flynn | 6.31% | 3,244,434 | $209.82M | Insider |
MIRM vs Biotech Stocks
Mirum Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.